top of page

GENOS IMMUNE PLUS

dna_01.jpeg
vial_trans.png
vial_trans.png

Epigenetic & Cell Intelligence
as a solution

the innovativ epigenetic modulation therapy for an optimized immune system

Immunomodulation
through corrected cell communication

Signal transduction molecules, the messengers of cell communication, are crucial for the transmission of signals within cells and enable them to respond to various stimuli. GENOS Immune Plus is a novel epigenetic application that modulates the immune system in a targeted, rapid, and, according to current knowledge, side-effect-free manner.

The signal transduction molecule RM31 contained in the product improves cell communication and represents a significant innovation in medicine to address current immunological challenges.

RM31
the key molecule

RM31 is a natural, organic key molecule found in all body cells. It plays a central role in cell communication, particularly in signal transduction and immune response, and positively influences numerous epigenetic and autocatalytic processes.

The research and application results of GENOS Immune Plus demonstrate that the signal transduction molecule RM31 enhances the immune modulation of CD4 and CD8 T cells, as well as NK cells. This is achieved through epigenetic regulation of S1P receptor function via RM31-induced phosphorylation. For detailed information, please visit our department.

Application

Each GENOS IMMUNE PLUS READY-TO-USE box contains 12 vials of 7.0 ml of RM31. We recommend administering 7.0 ml intravenously 2-3 times per week, with a 2-day interval between doses, without dilution, directly into a vein. An intravenous dose of 300 µg selenium 10 minutes before administration may have a positive effect on immune modulation.

Approval according to

§ 21 AMG

GENOS IMMUNE PLUS is a high-quality, extemporaneous prescription drug approved under Section 21 of the German Medicines Act (AMG) . It is manufactured in Germany according to the strictest GMP regulations and tested for sterility and quality by an external laboratory.

Manufactured in the pharmacy using the patented YENO QUANTUM ONE laboratory device, which enables epigenetically effective signal transduction of the RM31 molecule (signal transduction molecule). After 72 hours of epigenetic activation, GENOS IMMUNE PLUS has a shelf life of 6-8 weeks.

A notice!

The preservative-free injection solution is intended for single use only per 7.0 ml vial. It must be used immediately after opening the vial. Any unused portion should be discarded. Do not store the vials above 25°C and protect them from light. Please ensure that no direct cell phone radiation (electromagnetic radiation) comes near (50 cm away) the vial, as this may reduce or negate its effectiveness. To prevent radiation damage, the ampoules are wrapped in a radiation-protective cloth. Please store the ampoules in the protective cloth.

GENOS IMMUNE PLUS “READY TO USE BOX”

GENOS IMMUNE PLUS 12 x 7.0 ml vials

immuneplus copy.png
box_immun-open-front copy 2.png

Are you interested in using GENOS IMMUNE PLUS in your practice?

Contact us for detailed information

Please contact us at info@genos-immune.com to receive your login details as a GENOS physician. You can then register as a GENOS practitioner. After registration, you will receive access to the ordering process at the manufacturer's pharmacy. The use of GENOS Immune Plus medications is reserved exclusively for YENO-trained professionals.

Because GENOS IMMUNE PLUS is an epigenetic application, YENO places the highest priority on understanding its regulatory function and ensuring safety of use by its practitioners. Yeno therefore provides a free introduction to GENOS users to provide information on application safety, applied epigenetics, and the use of RM31 as a signal transduction molecule.

More GENOS products......

YENO EVOLUTION GMBH

Tuchlauben 7A | 1010 Vienna, Austria
Phone: +43 (1) 25 300 25 317
Email: info@genos-immune.com


Imprint | Privacy Policy

 

Contact us

bottom of page